Discovery on Target 2007--CHI's Fifth Annual Conference. Ion channels.
Beeton
Christine
C
University of California-Irvine, Irvine, CA 92697, USA. cbeeton@uci.edu
D000818:Animals; D015220:Calcium Channels / Q000187:drug effects; D006801:Humans; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels / Q000037:antagonists & inhibitors; D007473:Ion Channels / Q000037:antagonists & inhibitors*; D051664:Kv1.3 Potassium Channel / Q000037:antagonists & inhibitors; D062559:NAV1.8 Voltage-Gated Sodium Channel; D058919:Purinergic P2 Receptor Antagonists; D058486:Receptors, Purinergic P2X7; D051669:Shab Potassium Channels / Q000037:antagonists & inhibitors; D015222:Sodium Channels / Q000187:drug effects; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors
D015220:Calcium Channels; D051660:Intermediate-Conductance Calcium-Activated Potassium Channels; D007473:Ion Channels; C496923:KCNN4 protein, human; D051664:Kv1.3 Potassium Channel; D062559:NAV1.8 Voltage-Gated Sodium Channel; C546468:P2RX7 protein, human; D058919:Purinergic P2 Receptor Antagonists; D058486:Receptors, Purinergic P2X7; C568317:SCN10A protein, human; D051669:Shab Potassium Channels; D015222:Sodium Channels; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human